BACTERIOLOGICAL PROFILE OF STOOL SAMPLES IN HOSPITALISED PATIENTS WITH SPECIAL REFERENCE TO DIARRHOEAGENIC E. COLI
E. coli are bacteria that normally live in the intestine of humans and animals. In this study we examined the bacteriological profile in stool samples from patients suffering from diarrhea and studied the prevalence, serotypes and antibiotic susceptibility pattern of Diarrhoeagenic E. coli (DEC) in cases of diarrhea.
We examined 227 stool samples, out of which 100, i.e. 45.3% were reported as Diarrhoeagenic E. coli (DEC) as all these samples indicated bacterial infection on microscopy and no other diarrhoeagenic pathogen was isolated from them. Slide agglutination was done for all these strains using O157 antisera and they were sent for serotyping to CRI, Kasauli.
We found that approximately 52% of these patients presented with diarrhea, 31% with gastroenteritis and 17% with ulcerative colitis. The other major diarrhoeagenic pathogen isolated from stool samples after E. coli was Vibrio cholerae (5.2%). DEC isolates showed highest susceptibility to Amikacin (98%) and least to Augmentin (12.6%). Majority of DEC strains were found to be Enterotoxigenic E. coli (ETEC) i.e. 41%, followed by Enterohaemorrhagic E. coli (EHEC), i.e 26% and only 4% were Enteropathogenic E. coli (EPEC).Our study emphasizes that strains of E.coli have been shown to cause diarrhea by several different pathogenic mechanisms and DEC remains an important cause of diarrhea, particularly in developing countries.
Albert MJ, Faruque SM, Faruque AS, Neogi PK, Ansaruzzaman M, Bhuiyan NA, Alam K, and Akbar MS. (1995). “Controlled study of E.coli diarrheal infections in Bangladesh children”, J Clin Microbiol, Vol.33(4), pp.973-977.
Guerrant RL, Hughes JM, Lima NL, and Crane J. (1990). “Diarrhoea in developed and developing countries: magnitude, special settings and etiologies”, Rev Infect Dis, Vol.12(1), pp.S41-S45.
Gupta S, Soni NK, Kaur P, and Sood DK. (1992). “Verocytopathic activity of E. coli O157 and other O serogroups isolated from patients from patients of diarrhea”,Ind J. Med Res., Vol.95, pp.71-76.
McMillan AM, and McCartney. (2006). “The Enterobacteriaceae”, In Lunsden WHR, Burns S, McMillan AM and McCartney. (eds). (2006). Practical Medical Microbiology, 14th Edition, Elsevier, New Delhi, pp.365-367.
Nataro JP, and Kaper JB. (1998). “DiarrhoeagenicE.coli”, Clinical Microbiology Rev, Vol.11, pp.142-201.
National Committee for Clinical Laboratory Standards. (2002). “Performance standards for antimicrobial disk susceptibility test”, 7th edition, Villanova, PA: NCCLS 2002; Document M2-A7.
Parashar U, Umesh D, Bresee JS, Joseph S, Glass RI, and Roger I. (2003). “The global burden of diarrhoeal disease in children”, Bulletin of WHO, Vol.81(4), p.236.
Mayo SJ, Masell SY, Matee MI, Langeland N and Mylvaganam H. (2007). “Identification of Diarrheagenic E. coli isolated from infants and children in Dar es Salaam, Tanzania”, BMC Infectious diseases, Vol.174(3), pp.675-677.
Thompson Jr RB, and Miller JM. (2003). “Specimen Collection, Transport, and Processing : Bacteriology. In: Murray PR, Baron EJ, Jorgenson JH, Pfaller MA, Yolken RH (eds).Manual of Clinical. Microbiology 8th ed. 2003. American CDC Atlanta GA. 5.
World Health Organization. “Diarrhoea”, accessed through http://www.who.int/topics/diarrhoea/en
World Health Organisation. (2009). accessed through http://whqlibdoc.who.int/publications/2009/9789241598415_eng.pdf
- There are currently no refbacks.
Send mail to email@example.com with questions or comments about this web site.
International Journal of Medical and Pharma Research, All rights reserved.